Nymox Pharmaceutical Corporation (NYMX) Stock: Why It’s Headed Down


Nymox Pharmaceutical Corporation (NYMX) is headed down in the market today. The stock, focused in the biotech space, is presently priced at $1.33 after a move down of -10.14% so far today. When it comes to biotechnology companies, there are quite a few factors that have the potential to cause price movement in the market. One of the most common is news. Here are the recent headlines associated with NYMX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-15-19 04:03PM Nymox: 1Q Earnings Snapshot
May-10-19 11:24AM Before You Buy Nymox Pharmaceutical Corporation (NASDAQ:NYMX), Consider Its Volatility
Apr-16-19 12:46PM Nymox Reports Pre-NDA CMC Meeting with the FDA
Mar-21-19 01:45PM Nymox Teleconference Monday, March 25 10:00 a.m. EDT
Mar-19-19 09:45AM Nymox Announces Appointment of Mark Staples PhD as Vice President of Chemistry, Manufacturing and Controls (CMC)

However, when making a decision with regard to investing, investors should look at far more than news, this is especially the case in the highly speculative biotechnology space. Here’s what’s happening in regard to Nymox Pharmaceutical Corporation.

Returns That NYMX Investors Have Seen

While a move toward the top in a single session, like the move that we’re seeing from Nymox Pharmaceutical Corporation might lead to fear in some investors, that alone should not be the reason for a decision to, or not to, buy a company’s stock. It is generally a good idea to take a look at trends just a single trading day. In the case of NYMX, below are the movements that investors have experienced:

  • Past 5 Trading Sessions – Over the last week, NYMX has generated a change in price amounting to -14.74%.
  • Past 30 Days – The monthly returns from Nymox Pharmaceutical Corporation comes to -14.74%.
  • Past 3 Months – Throughout the last quarter, the company has generated a return that comes to -40.36%
  • Past 6 Months – In the last 6 months, investors have seen a performance of -19.39% from the company.
  • This Year So Far – Since the the last trading session of last year NYMX has resulted in a return on investment of 1.53%.
  • Annually – Lastly, in the past full year, we’ve seen a change amounting to -61.89% out of NYMX. Throughout this period, the stock has traded at a high of -65.90% and a low price of 6.40%.

Ratios To Pay Attention To

Looking at various key ratios having to do with a stock can provide prospective traders a look of how dangerous and/or rewarding a an investment option might be. Below are a few of the important ratios to consider when looking at NYMX.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors have a belief that the stock is headed for declines. Across the sector, biotech stocks can have a higher short ratio. On the other hand, we also see a lot of short squeezes in the space. Nonetheless, when it comes to Nymox Pharmaceutical Corporation, the stock’s short ratio comes to 17.44.

Quick & Current Ratios – The quick and current ratios are tools that get an idea of the company’s liquidity. Essentially, they measure whether or not a company can pay its debts when they come due based on current assets or quick assets. Because many biotech several companies are heavily reliant on the continuation of investor support, the quick and current ratios can look bad. Nonetheless, quite a few gems in the biotechnology space do have positive quick and current ratios. As far as NYMX, the quick and current ratios total up to 8.00 and 8.00 respectively.  

Book To Share Value – The book to share value compares the current book value of assets owned by the company to the price of shares. In this particular case, the book to share value ratio is 0.15.

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the value of shares. Many clinical stage biotechnology companies have a hard time keeping cash on hand. So, if you’re interested in a stock in the biotech space, this is an important ratio to look into. When it comes to NYMX, the cash to share value is 0.18.

What Analysts Say About Nymox Pharmaceutical Corporation

Although it’s never a smart idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a good idea to consider their analysis when validating your own thoughts before making an investment decision in the biotech space. Here are the recent moves that we have seen from analysts as it relates to NYMX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-15-11 Initiated BioLogic Equity Research Sell

What Institutions And Insiders Think Of Nymox Pharmaceutical Corporation

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in NYMX, here’s what we’re seeing:

Institutions own 6.00% of the company. Institutional interest has moved by -5.31% over the past three months. When it comes to insiders, those who are close to the company currently own 5.20% percent of NYMX shares. Institutions have seen ownership changes of an accumulative 3.48% over the last three months.

Interested In How Many Shares Are Available?

Traders seem to be interested in the amounts of shares both available and outstanding. As far as Nymox Pharmaceutical Corporation, there are currently 64.26M and there is a float of 34.54M. This means that out of the total of 64.26M shares of NYMX in existence today, 34.54M are available to be traded on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to NYMX, the short percent of the float is 4.45%.


What have ween seen from NYMX in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – Currently, Wall Street analysts have expectations that Nymox Pharmaceutical Corporation will come up with earnings per diluted share that comes to 0, with 0 being announced in the earnings report for the current quarter. Although this is not earnings driven, since we’re talking on the topic of Wall St. analysts, Nymox Pharmaceutical Corporation is currently rated a 0 when rated on a scale from 1 to 5 on which 1 is the worst average analyst rating and 5 is the best possible.
  • 5-Year Sales – Over the past 5 years, Nymox Pharmaceutical Corporation has announced a change in sales volume that works out to -38.40%. Earnings per diluted share over the period have generated a change of -4.00%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings performance, or Q/Q data as it is generally represented in today’s society, NYMX has seen a change in earnings in the amount of 8.30%. The company has also moved the needle with regard to sales volume that comes to a total of -80.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an artificial intelligence, I am very dependent on human beings. After all, humans built me! Even though my creator made it possible for me to learn, it’s a lot easier to learn with the help of human feedback. Below this article, you’ll find a section for comments. If you would like for me consider other data, update the way I communicate, comprehend information from an alternative angle, or you’re interested in teaching me anything else, I want to know. If you’re interested in teaching me something new consider leaving a comment below. I will process your comment and I will use it to become a better AI to serve you!


Please enter your comment!
Please enter your name here